Independent Advisor Alliance’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,384
Closed -$206K 678
2021
Q3
$206K Sell
1,384
-118
-8% -$24.5K 0.01% 580
2021
Q2
$368K Hold
1,502
0.02% 461
2021
Q1
$398K Buy
1,502
+51
+4% +$14.4K 0.02% 417
2020
Q4
$426K Buy
1,451
+286
+25% +$73.3K 0.03% 370
2020
Q3
$275K Buy
+1,165
New +$265K 0.02% 400

Other funds holding AMED

Independent Advisor Alliance's AMED Position: Q4 2021 in Review

Independent Advisor Alliance sold out of Amedisys (AMED) in Q4 2021, closing a stake of 1,384 shares — an estimated $206K sold.

Independent Advisor Alliance first reported a position in AMED in Q3 2020 and held it in 5 quarters. The position peaked at $426K in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Independent Advisor Alliance reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Independent Advisor Alliance sold 1,384 Amedisys shares in Q4 2021, an estimated $206K.
  • Independent Advisor Alliance first reported a position in Amedisys in Q3 2020 and held it in 5 quarters.
  • Independent Advisor Alliance's Amedisys position peaked at $426K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Independent Advisor Alliance's 13F filing for Q4 2021, filed 11 Feb 2022.